Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Methotrexate in rheumatoid arthritis].

M Alamo1, M Grisanti

  • 1Departamento de Medicina, Hospital Clínico de la Universidad de Chile, Santiago.

Revista Medica De Chile
|June 1, 1991
PubMed
Summary

Methotrexate shows promise for rheumatoid arthritis patients resistant to other therapies, with success rates ranging from 39-88%. While generally safe, potential side effects like pneumonitis and teratogenicity require careful monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generalized Degenerative Joint Disease in Osteoprotegerin (Opg) Null Mutant Mice.

Veterinary pathology·2015
Same author

Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery.

Surgical endoscopy·2008
Same author

Tumour necrosis factor (TNF)alpha -308 G/G promoter polymorphism and TNFalpha levels correlate with a better response to adalimumab in patients with rheumatoid arthritis.

Scandinavian journal of rheumatology·2007
Same author

Characterization of osteoclast precursors in human blood.

British journal of haematology·2000
Same author

[Primary muscle lymphoma. Computerized tomography features in a case].

La Radiologia medica·1998
Same author

[Comparison of the efficacy of intraarticular and intraarterial injections of two betamethasone preparations in patients with osteoarthritis or epicondilytis].

Revista medica de Chile·1998

Area of Science:

  • Rheumatology
  • Pharmacology

Context:

  • Rheumatoid arthritis (RA) often requires multifaceted treatment approaches.
  • Patients refractory to traditional therapies like gold salts, d-penicillamine, and antimalarials need alternative options.

Purpose:

  • To evaluate the efficacy and safety of methotrexate in patients with rheumatoid arthritis (RA) refractory to other treatments.
  • To review reported success rates and side effect profiles of methotrexate in RA management.

Summary:

  • Methotrexate demonstrates significant efficacy in a substantial percentage of RA patients unresponsive to other disease-modifying antirheumatic drugs (DMARDs), with reported success rates between 39% and 88%.
  • The precise mechanism of action is not fully elucidated but is presumed to involve anti-inflammatory and immunosuppressive pathways.
  • Common side effects are typically mild and manageable through dose adjustment; however, serious adverse events such as pneumonitis (a hypersensitivity reaction) and potential teratogenicity necessitate cautious administration and monitoring.

Impact:

  • Methotrexate may represent a valuable therapeutic option for refractory rheumatoid arthritis, potentially improving patient outcomes.
  • Further large-scale studies are warranted to solidify its role and optimize its use in RA treatment protocols.
  • Understanding potential risks, including hepatotoxicity and teratogenicity, is crucial for safe and effective clinical application.

Related Experiment Videos